• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏去神经消融术治疗血管迷走性晕厥的效果:通过初步解剖消融和高频电刺激定位神经节丛

Effects of cardioneuroablation for vasovagal syncope: ganglionated plexus localization by tentative anatomical ablation and high-frequency electrical stimulation.

作者信息

Li Chenze, Hu Yingying, Li Yi, Zeng Ziyue, Yu Wenxi, Zhou Zhen, Qiu Hao, He Bo, Lu Zhibing

机构信息

Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.

Hubei Provincial Clinical Research Center for Interventional Diagnosis and Treatment of Cardiovascular Diseases, Institute of Myocardial Injury and Repair, Wuhan University, Wuhan, 430071, Hubei, China.

出版信息

BMC Cardiovasc Disord. 2025 Jul 14;25(1):505. doi: 10.1186/s12872-025-04933-z.

DOI:10.1186/s12872-025-04933-z
PMID:40660118
Abstract

BACKGROUND

Cardioneuroablation is increasingly being adopted as a treatment for vasovagal syncope (VVS). Identification of the cardiac ganglionated plexus (GP) is a critical factor influencing the outcome of the procedure. This study sought to compare the efficacy of tentative anatomical ablation (TAA) and high-frequency electrical stimulation (HFS) in locating the GP.

METHODS

A total of 58 patients diagnosed with VVS were consecutively enrolled, including 46 patients with the cardioinhibitory type and 12 patients with the mixed type who exhibited a significant decrease in heart rate (HR). The first 19 enrolled patients simultaneously underwent HFS- and TAA-guided GP localization. All patients underwent anatomical GP ablation.

RESULTS

The number of GP sites with a positive response to TAA was significantly greater than those from HFS (15 ± 4 per person vs. 12 ± 4 per person; p < 0.001). Following anatomical ablation, the patients exhibited an increase in HR (69 ± 13 bpm vs. 91 ± 13 bpm, p < 0.001), a reduction in sinus node recovery time (1155 ± 169 ms vs. 934 ± 162 ms, p < 0.001), an enhancement of atrioventricular conduction (Wenckebach point: 418 ± 87 ms vs. 338 ± 41 ms; effective refractory period of atrioventricular node: 334 ± 84 ms vs. 254 ± 54 ms, all p < 0.001), and a reduction in heart rate variability (HRV) (HRV: 146 ± 64 ms vs. 67 ± 29 ms; high frequency: 309.18 ± 99.42 vs. 24.21 ± 12.73, all p < 0.001). During a median follow-up of 18 months, the rate of freedom from syncope recurrent was 94.8%, with no statistically significant differences observed in age, gender, or type of head-up tilt test.

CONCLUSIONS

In GP localization, TAA-guided responses demonstrated greater precision and wider distribution compared to HFS-guided approaches. Anatomical GP ablation can significantly decrease autonomic tone and prevent syncope in patients with VVS.

CLINICAL TRIAL NUMBER

Not applicable.

摘要

背景

心脏神经消融术越来越多地被用作血管迷走性晕厥(VVS)的一种治疗方法。识别心脏神经节丛(GP)是影响该手术结果的关键因素。本研究旨在比较试探性解剖消融(TAA)和高频电刺激(HFS)在定位GP方面的疗效。

方法

连续纳入58例诊断为VVS的患者,其中46例为心脏抑制型,12例为混合型,均表现出心率(HR)显著下降。前19例纳入患者同时接受了HFS和TAA引导的GP定位。所有患者均接受了解剖学GP消融。

结果

TAA引导下出现阳性反应的GP部位数量显著多于HFS引导下的数量(每人15±4个 vs. 每人12±4个;p<0.001)。解剖消融后,患者的HR增加(69±13次/分 vs. 91±13次/分,p<0.001),窦房结恢复时间缩短(1155±169毫秒 vs. 934±162毫秒,p<0.001),房室传导增强(文氏点:418±87毫秒 vs. 338±41毫秒;房室结有效不应期:334±84毫秒 vs. 254±54毫秒,均p<0.001),心率变异性(HRV)降低(HRV:146±64毫秒 vs. 67±29毫秒;高频:309.18±99.42 vs. 24.21±12.73,均p<0.001)。在中位随访18个月期间,晕厥复发率为94.8%,在年龄、性别或直立倾斜试验类型方面未观察到统计学显著差异。

结论

在GP定位中,与HFS引导方法相比,TAA引导的反应显示出更高的精度和更广泛的分布。解剖学GP消融可显著降低自主神经张力并预防VVS患者的晕厥。

临床试验编号

不适用。

相似文献

1
Effects of cardioneuroablation for vasovagal syncope: ganglionated plexus localization by tentative anatomical ablation and high-frequency electrical stimulation.心脏去神经消融术治疗血管迷走性晕厥的效果:通过初步解剖消融和高频电刺激定位神经节丛
BMC Cardiovasc Disord. 2025 Jul 14;25(1):505. doi: 10.1186/s12872-025-04933-z.
2
Cardioneuroablation in patients with vasovagal syncope: An updated systematic review and meta-analysis.血管迷走性晕厥患者的心脏神经消融:一项更新的系统评价和荟萃分析。
Heart Rhythm. 2025 Feb;22(2):526-535. doi: 10.1016/j.hrthm.2024.07.103. Epub 2024 Jul 25.
3
The Efficacy of Left Atrial vs Biatrial Cardioneuroablation in Patients With Vasovagal Syncope: A Randomized Clinical Trial.血管迷走性晕厥患者左心房与双心房心脏神经消融术的疗效:一项随机临床试验
JACC Clin Electrophysiol. 2025 Jun;11(6):1265-1276. doi: 10.1016/j.jacep.2025.01.019. Epub 2025 Mar 19.
4
The Efficacy of Cardioneuroablation versus Midodrine in Patients with Vasovagal Syncope: Design and Rationale for the CAMPAIGN Trial.心脏神经消融术与米多君治疗血管迷走性晕厥患者的疗效比较:CAMPAIGN试验的设计与原理
J Interv Card Electrophysiol. 2025 Mar;68(2):257-265. doi: 10.1007/s10840-025-02029-4. Epub 2025 Mar 21.
5
Role of serotonin and serotonergic-related metabolites in the pathogenesis of vasovagal syncope.血清素及血清素相关代谢产物在血管迷走性晕厥发病机制中的作用。
Heart Rhythm. 2025 Jul;22(7):1810-1817. doi: 10.1016/j.hrthm.2024.09.047. Epub 2024 Sep 21.
6
First experience with a new tool for automatic mapping of fragmented signals in a case report of cardioneuroablation.心脏神经消融病例报告中使用新型工具自动映射碎片化信号的首次经验。
Future Cardiol. 2025 Apr;21(5):265-268. doi: 10.1080/14796678.2025.2476313. Epub 2025 Mar 9.
7
Right anterior ganglionated plexus: The primary target of cardioneuroablation?右侧前神经节丛:心脏神经消融的主要靶点?
Heart Rhythm. 2019 Oct;16(10):1545-1551. doi: 10.1016/j.hrthm.2019.07.018. Epub 2019 Jul 19.
8
Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.心房颤动和典型心房扑动的根治性导管消融术:系统评价与经济评估
Health Technol Assess. 2008 Nov;12(34):iii-iv, xi-xiii, 1-198. doi: 10.3310/hta12340.
9
Increased adrenocortical activity in patients with vasovagal syncope.血管迷走性晕厥患者肾上腺皮质活动增加。
Auton Neurosci. 2024 Aug;254:103196. doi: 10.1016/j.autneu.2024.103196. Epub 2024 Jun 27.
10
Selective ablation of atrial ganglionated plexus attenuates vasovagal reflex in a canine model.在犬模型中,选择性消融心房神经节丛可减弱迷走神经反射。
Pacing Clin Electrophysiol. 2019 Jan;42(1):13-19. doi: 10.1111/pace.13547. Epub 2018 Nov 30.

本文引用的文献

1
The Efficacy of Left Atrial vs Biatrial Cardioneuroablation in Patients With Vasovagal Syncope: A Randomized Clinical Trial.血管迷走性晕厥患者左心房与双心房心脏神经消融术的疗效:一项随机临床试验
JACC Clin Electrophysiol. 2025 Jun;11(6):1265-1276. doi: 10.1016/j.jacep.2025.01.019. Epub 2025 Mar 19.
2
Cardioneuroablation guided by real-time spectral analysis: The Omnipolar Technology Near Field.实时频谱分析引导下的心脏神经消融:全极技术近场
HeartRhythm Case Rep. 2024 Sep 1;10(12):907-911. doi: 10.1016/j.hrcr.2024.08.027. eCollection 2024 Dec.
3
Cardioneuroablation for the treatment of reflex syncope and functional bradyarrhythmias: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS) and the Latin American Heart Rhythm Society (LAHRS).
心脏神经消融术治疗反射性晕厥和功能性心动过缓:欧洲心脏病学会心律协会 (EHRA)、心律学会 (HRS)、亚太心律学会 (APHRS) 和拉丁美洲心律学会 (LAHRS) 的科学声明。
Europace. 2024 Aug 3;26(8). doi: 10.1093/europace/euae206.
4
Cardioneuroablation in patients with vasovagal syncope: An updated systematic review and meta-analysis.血管迷走性晕厥患者的心脏神经消融:一项更新的系统评价和荟萃分析。
Heart Rhythm. 2025 Feb;22(2):526-535. doi: 10.1016/j.hrthm.2024.07.103. Epub 2024 Jul 25.
5
Effectiveness of cardioneuroablation in different subtypes of vasovagal syncope.心脏神经消融术在不同亚型血管迷走性晕厥中的有效性。
J Geriatr Cardiol. 2024 Jun 28;21(6):651-657. doi: 10.26599/1671-5411.2024.06.004.
6
Cardioneuroablation for vasovagal syncope: insights on patients' selection, centre settings, procedural workflow and endpoints-results from an European Heart Rhythm Association survey.心脏神经消融治疗血管迷走性晕厥:患者选择、中心设置、程序流程和终点的见解——来自欧洲心律协会调查的结果。
Europace. 2024 May 2;26(5). doi: 10.1093/europace/euae106.
7
Cardioneuroablation for Cardioinhibitory Vasovagal Syncope: Rationale, Approaches, and Its Role in Long-Term Management.用于心脏抑制型血管迷走性晕厥的心脏神经消融术:原理、方法及其在长期管理中的作用。
Curr Cardiovasc Risk Rep. 2024 Apr;18(4):55-64. doi: 10.1007/s12170-024-00736-7. Epub 2024 Apr 16.
8
Cardioneuroablation as a strategy to prevent pacemaker implantation in young patients with vasovagal syncope.心脏神经消融术作为预防血管迷走性晕厥年轻患者植入起搏器的一种策略。
Int J Cardiol Heart Vasc. 2024 Feb 13;51:101360. doi: 10.1016/j.ijcha.2024.101360. eCollection 2024 Apr.
9
Global prevalence of vasovagal syncope: A systematic review and meta-analysis.血管迷走性晕厥的全球患病率:一项系统评价和荟萃分析。
Glob Epidemiol. 2024 Jan 6;7:100136. doi: 10.1016/j.gloepi.2024.100136. eCollection 2024 Jun.
10
Long-term outcomes of cardioneuroablation with and without extra-cardiac vagal stimulation confirmation in severe cardioinhibitory neurocardiogenic syncope.严重心脏抑制性神经心源性晕厥中行心外迷走神经刺激确认的心神经消融术的长期疗效。
J Cardiovasc Electrophysiol. 2024 Apr;35(4):641-650. doi: 10.1111/jce.16188. Epub 2024 Jan 19.